Preventing and containing infectious diseases, such as HIV/AIDS, malaria, measles, COVID-19, and influenza
Explore the latest public health research and insights about infectious diseases.
The current pipeline for new antibiotics is “on the verge of collapse” within the next four to eight years—and a key reason is that antibiotic makers can’t stay in business.
Looking for prominent public health experts in the field of infectious diseases? They’re here at the Bloomberg School of Public Health.
George Dimopoulos, PhD, MBA, studies vector-borne diseases and how mosquitoes can be rendered incapable of transmitting human pathogens.
Andy Pekosz, PhD, investigates the replication and disease potential of respiratory viruses including influenza, SARS-CoV-2 and other emerging viruses.
